Recently Posted Guidance Documents

Recently Posted Guidance Documents

10/24/2019 - Breast Implants - Certain Labeling Recommendations to Improve Patient Communication: Draft Draft Guidance for Industry and Food and Drug Administration Staff 10/24/2019 - Drug Products Labeled as Homeopathic Guidance for FDA Staff and Industry: Draft Revised Draft 10/24/2019 - Postmarketing Studies and Clinical Trials—Implementation of Section 505(o)(3) of the Federal Food, Drug, and Cosmetic Act Guidance for Industry 10/22/2019 - Identification of Manufacturing Establishments in Applications Submitted to CBER and CDER Questions and Answers